Find a Supplier
ADD YOUR COMPANY
Evercyte helps pioneer standardized production of spheroids for tissue engineering
Contact Us Subscribe to Newsletter
Contact Supplier

Contact Supplier

To get in touch with Evercyte GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    Evercyte helps pioneer standardized production of spheroids for tissue engineering

    Evercyte GmbH News Releases

    Find the latest News from Evercyte GmbH

    Page 2 of 5
    Evercyte helps pioneer standardized production of spheroids for tissue engineering
    Evercyte helps pioneer standardized production of spheroids for tissue engineering

    Friday 15th July 2022

    By  Evercyte GmbH Learn More >
    Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon
    Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon

    Monday 23rd May 2022

    By  Evercyte GmbH Learn More >
    Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit
    Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit

    Tuesday 22nd March 2022

    By  Evercyte GmbH Learn More >
    Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines
    Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines

    Wednesday 19th January 2022

    By  Evercyte GmbH Learn More >
    Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences
    Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences

    Wednesday 15th December 2021

    By  Evercyte GmbH Learn More >
    New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology
    New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology

    Friday 24th September 2021

    By  Evercyte GmbH Learn More >
    MDimune and Evercyte form partnership for developing tumor-targeting EVs
    MDimune and Evercyte form partnership for developing tumor-targeting EVs

    Tuesday 13th April 2021

    By  Evercyte GmbH Learn More >
    Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting
    Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting

    Thursday 14th November 2019

    By  Evercyte GmbH Learn More >
    Evercyte bringing latest cell-based advances to BIO-Europe Hamburg
    Evercyte bringing latest cell-based advances to BIO-Europe Hamburg

    Monday 28th October 2019

    By  Evercyte GmbH Learn More >
    Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama
    Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama

    Wednesday 2nd October 2019

    By  Evercyte GmbH Learn More >
    Evercyte brings new EV research focus to BIO 2019 Philadelphia
    Evercyte brings new EV research focus to BIO 2019 Philadelphia

    Wednesday 29th May 2019

    By  Evercyte GmbH Learn More >
    Evercyte brings new EV research focus to ESACT Copenhagen
    Evercyte brings new EV research focus to ESACT Copenhagen

    Tuesday 30th April 2019

    By  Evercyte GmbH Learn More >
    Page 2 of 5
    Full Supplier Profile